C12Y 301/04052
Cyclic-guanylate-specific phosphodiesterase
Official title: Cyclic-guanylate-specific phosphodiesterase (3.1.4.52)
C12Y301/04052 (Cyclic-guanylate-specific phosphodiesterase) appears on 3 US grants and 4 published applications in this corpus.
Search patents in C12Y- Granted patents
- 3
- Published applications
- 4
- Assignees
- 3
- Inventors
- 20
- Latest grant
- 25 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2020 | 0 | 1 |
| 2021 | 2 | 2 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
By publication year.
Recent patents
- Composition comprising biofilm forming Bacillus25 Nov 2025US 12,478,069 B2Chr. Hansen A/S
- Genome-wide rationally-designed mutations leading to enhanced lysine production in E. coli3 Aug 2021US 11,078,458 B2Inscripta, Inc.
- Genome-wide rationally-designed mutations leading to enhanced lysine production in E. coli16 Feb 2021US 10,920,189 B2Inscripta, Inc.
- Composition comprising biofilm forming bacillus25 Aug 2022US 2022/0264893 A1Chr. Hansen A/S
- Recombinant Microorganism for Producing 2,3-Butanediol and a Method of Production of 2,3-Butanediol21 Oct 2021US 2021/0324345 A1CPC Corporation, Taiwan
- Genome-wide rationally-designed mutations leading to enhanced lysine production in e. coli27 May 2021US 2021/0155894 A1Inscripta, Inc.
- Genome-wide rationally-designed mutations leading to enhanced lysine production in e. coli24 Dec 2020US 2020/0399586 A1Inscripta, Inc.
Most cited
By later US patents